Adaptive Biotechnologies (ADPT) Profit After Tax (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Profit After Tax of -$20.0 million for Q1 2026, down 46.94% sequentially from -$13.6 million in Q4 2025, and up 32.9% YoY from -$15.1 million in Q1 2025.
Adaptive Biotechnologies (ADPT) Profit After Tax (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported Profit After Tax for 9 years, with the latest figure at -$20.0 million in Q1 2026.
- Quarterly Profit After Tax rose 32.9% year-over-year to -$20.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.7 million (up 64.96% YoY) and the FY2025 annual result came in at -$59.5 million, up 62.72% from the prior year.
- Profit After Tax fell to -$20.0 million in Q1 2026 per ADPT's latest filing, from -$13.6 million in the prior quarter.
- Over five years, Profit After Tax peaked at $9.5 million in Q3 2025 and troughed at -$69.4 million in Q4 2023.
- A 5-year average of -$39.1 million and a median of -$45.3 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2023 and 2025: Profit After Tax plunged 72.87% in 2023, then surged 129.76% in 2025.
- Over 5 years, Profit After Tax stood at -$40.2 million in 2022, then slumped by 72.87% to -$69.4 million in 2023, then jumped by 51.45% to -$33.7 million in 2024, then soared by 59.6% to -$13.6 million in 2025, then tumbled by 46.94% to -$20.0 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$20.0 million, -$13.6 million, and $9.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 1.74 Bn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 258.00 Mn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | -85.09 Mn |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 256.84 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 334.00 Mn |
| 10 | Adaptive Biotechnologies | 3.83 Bn | 3.61 Bn | 52.17 Mn | -20.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.02 Mn |
| Dec 31, 2025 | -13.62 Mn |
| Sep 30, 2025 | 9.55 Mn |
| Jun 30, 2025 | -25.61 Mn |
| Mar 31, 2025 | -29.83 Mn |
| Dec 31, 2024 | -33.72 Mn |
| Sep 30, 2024 | -32.07 Mn |
| Jun 30, 2024 | -46.22 Mn |
| Mar 31, 2024 | -47.53 Mn |
| Dec 31, 2023 | -69.44 Mn |
| Sep 30, 2023 | -50.33 Mn |
| Jun 30, 2023 | -47.81 Mn |
| Mar 31, 2023 | -57.70 Mn |
| Dec 31, 2022 | -40.17 Mn |
| Sep 30, 2022 | -45.32 Mn |
| Jun 30, 2022 | -52.08 Mn |
| Mar 31, 2022 | -62.74 Mn |
| Dec 31, 2021 | -61.45 Mn |
| Sep 30, 2021 | -56.00 Mn |
| Jun 30, 2021 | -56.00 Mn |